Phase 3 Randomised, Double-Blind, Placebo Controlled, Multicentre Study to Compare the Efficacy and Safety of Lenalidomide (CC-5013) Plus R-CHOP Chemotherapy (R2-CHOP) Versus Placebo Plus R-CHOP Chemotherapy in Subjects with Previously Untreated Activated B-Cell Type Diffuse Large B-Cell Lymphoma (ROBUST)

Project: Research

Project Details

Project Description

SERP Reference Number: HREC/14/MH/223
SSA Reference Number: SSA/15/MonH/4
Monash Health HREC Ref: 15013X
Effective start/end date12/06/1911/06/24


  • clinical trial
  • Lymphoma
  • chemotherapy